宣东平, 乔进, 赵彦, 陈霞. 用药教育联合信息化随访对门诊2型糖尿病患者治疗效果的影响[J]. 实用临床医药杂志, 2021, 25(16): 81-84. DOI: 10.7619/jcmp.20212369
引用本文: 宣东平, 乔进, 赵彦, 陈霞. 用药教育联合信息化随访对门诊2型糖尿病患者治疗效果的影响[J]. 实用临床医药杂志, 2021, 25(16): 81-84. DOI: 10.7619/jcmp.20212369
XUAN Dongping, QIAO Jin, ZHAO Yan, CHEN Xia. Influence of medication education combined with information follow-up on therapeutic effect in patients with type 2 diabetes mellitus in clinic[J]. Journal of Clinical Medicine in Practice, 2021, 25(16): 81-84. DOI: 10.7619/jcmp.20212369
Citation: XUAN Dongping, QIAO Jin, ZHAO Yan, CHEN Xia. Influence of medication education combined with information follow-up on therapeutic effect in patients with type 2 diabetes mellitus in clinic[J]. Journal of Clinical Medicine in Practice, 2021, 25(16): 81-84. DOI: 10.7619/jcmp.20212369

用药教育联合信息化随访对门诊2型糖尿病患者治疗效果的影响

Influence of medication education combined with information follow-up on therapeutic effect in patients with type 2 diabetes mellitus in clinic

  • 摘要:
      目的   探讨用药教育联合信息化随访对门诊2型糖尿病(T2DM)患者治疗效果的影响。
      方法   将最终纳入的199例T2DM患者随机分为观察组100例和对照组99例,对照组患者接受常规治疗,观察组患者在常规治疗基础上给予临床药师的用药教育与信息化随访。干预6个月后,比较2组患者的血压、血脂、血糖等生化指标。
      结果   干预6个月后,观察组空腹血糖、糖化血红蛋白、收缩压、舒张压、高密度脂蛋白、甘油三酯、总胆固醇均较干预前降低,体质量指数、糖化血红蛋白 < 7%比率、血压达标率均较治疗前升高,差异有统计学意义(P < 0.05)。对照组干预6个月后舒张压、低密度脂蛋白、总胆固醇、体质量指数均较治疗前升高,差异有统计学意义(P < 0.05)。干预6个月后,观察组空腹血糖、糖化血红蛋白、总胆固醇水平低于对照组,糖化血红蛋白 < 7%比率、血压达标率高于对照组,差异有统计学意义(P < 0.05)。干预后,观察组患者用药依从性评分为(0.32±0.11)分,低于对照组患者的(0.77±0.65)分,差异有统计学意义(P < 0.05)。
      结论   临床药师对T2DM患者进行定期的用药教育与信息化随访,可提高患者的血糖、血脂达标率和用药依从性,强化临床治疗效果。

     

    Abstract:
      Objective   To explore the influence of medication education combined with information follow-up on therapeutic effect in patients with type 2 diabetes mellitus (T2DM) in clinic.
      Methods   A total of 199 patients with T2DM were randomly divided into observation group with 100 cases and control group with 99 cases. The patients in the control group were treated with routine treatment, while the patients in the observation group were treated with medication education and information follow-up by clinical pharmacists on the basis of routine treatment. After 6 months of intervention, the biochemical indexes such as blood pressure, blood lipid and blood sugar were compared between the two groups.
      Results   After 6 months of intervention, the fasting blood glucose, glycosylated hemoglobin, systolic blood pressure, diastolic blood pressure, high-density lipoprotein, triglyceride and total cholesterol in the observation group were significantly lower than those before intervention, while the body mass index, the ratio of patients with glycosylated hemoglobin less than 7% and the standard rate of blood pressure were significantly higher than those before treatment (P < 0.05). After 6 months of intervention, the diastolic blood pressure, low-density lipoprotein, total cholesterol and body mass index in the control group were significantly higher than those before treatment (P < 0.05). After 6 months of intervention, the fasting blood glucose, glycosylated hemoglobin and total cholesterol in the observation group were significantly lower than those in the control group, while the ratio of patients with glycosylated hemoglobin less than 7% and the standard rate of blood pressure were significantly higher than those in the control group (P < 0.05). After the intervention, the score of medication compliance in the observation group was (0.32±0.11), which was significantly lower than (0.77±0.65) in the control group (P < 0.05).
      Conclusion   Regular medication education and information follow-up by clinical pharmacists for T2DM patients can improve the standard rates of blood glucose, blood lipid and medication compliance, and strengthen the therapeutic effect.

     

/

返回文章
返回